Global Virus Cryopreservation Market Growth 2025-2031
Description
The global Virus Cryopreservation market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Virus cryopreservation is a biotechnology that allows long-term preservation of virus in living tissues or in suspension medium by freezing them at very low temperatures, usually below -70°C. The aim of virus cryopreservation is to maintain the viability and infectivity of the virus without altering its genetic stability. Virus cryopreservation requires the use of cryo-protectant agents, such as glycerol, dimethyl sulfoxide (DMSO) or fetal bovine serum (FBS), to prevent ice crystal formation and damage to the virus structure.
United States market for Virus Cryopreservation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Virus Cryopreservation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Virus Cryopreservation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Virus Cryopreservation players cover ATCC, Kerafast, Virovek, Virusys Corporation, Microbix Biosystems, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Virus Cryopreservation Industry Forecast” looks at past sales and reviews total world Virus Cryopreservation sales in 2024, providing a comprehensive analysis by region and market sector of projected Virus Cryopreservation sales for 2025 through 2031. With Virus Cryopreservation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virus Cryopreservation industry.
This Insight Report provides a comprehensive analysis of the global Virus Cryopreservation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Virus Cryopreservation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virus Cryopreservation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virus Cryopreservation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virus Cryopreservation.
This report presents a comprehensive overview, market shares, and growth opportunities of Virus Cryopreservation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Plant Virus Freezing Solution
Animal Virus Freezing Solution
Segmentation by Application:
Medical
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ATCC
Kerafast
Virovek
Virusys Corporation
Microbix Biosystems
Eureka Therapeutic
Vigene Biosciences
Oxford Biomedica
Cobra Biologics
Lonza
BioReliance
Key Questions Addressed in this Report
What is the 10-year outlook for the global Virus Cryopreservation market?
What factors are driving Virus Cryopreservation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Virus Cryopreservation market opportunities vary by end market size?
How does Virus Cryopreservation break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Virus cryopreservation is a biotechnology that allows long-term preservation of virus in living tissues or in suspension medium by freezing them at very low temperatures, usually below -70°C. The aim of virus cryopreservation is to maintain the viability and infectivity of the virus without altering its genetic stability. Virus cryopreservation requires the use of cryo-protectant agents, such as glycerol, dimethyl sulfoxide (DMSO) or fetal bovine serum (FBS), to prevent ice crystal formation and damage to the virus structure.
United States market for Virus Cryopreservation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Virus Cryopreservation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Virus Cryopreservation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Virus Cryopreservation players cover ATCC, Kerafast, Virovek, Virusys Corporation, Microbix Biosystems, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Virus Cryopreservation Industry Forecast” looks at past sales and reviews total world Virus Cryopreservation sales in 2024, providing a comprehensive analysis by region and market sector of projected Virus Cryopreservation sales for 2025 through 2031. With Virus Cryopreservation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virus Cryopreservation industry.
This Insight Report provides a comprehensive analysis of the global Virus Cryopreservation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Virus Cryopreservation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virus Cryopreservation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virus Cryopreservation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virus Cryopreservation.
This report presents a comprehensive overview, market shares, and growth opportunities of Virus Cryopreservation market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Plant Virus Freezing Solution
Animal Virus Freezing Solution
Segmentation by Application:
Medical
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ATCC
Kerafast
Virovek
Virusys Corporation
Microbix Biosystems
Eureka Therapeutic
Vigene Biosciences
Oxford Biomedica
Cobra Biologics
Lonza
BioReliance
Key Questions Addressed in this Report
What is the 10-year outlook for the global Virus Cryopreservation market?
What factors are driving Virus Cryopreservation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Virus Cryopreservation market opportunities vary by end market size?
How does Virus Cryopreservation break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
116 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Virus Cryopreservation by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Virus Cryopreservation by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
